参考文献/References:
[1]王婧涵,李嘉,赵新颜,等.慢性乙型肝炎和乙肝肝硬化及原发性肝癌血清肿瘤标志物的检测意义[J].临床和实验医学杂志,2013,12(21):1702-1705.
[2]李嘉妍,宋金云,王建芳,等.AFP、CA19-9、CEA联合检测对原发性肝癌的早期诊断价值[J].临床肝胆病杂志,2017,33(7):1291-1295.
[3]龚信建,林晓春.电化学发光法检测消化道肿瘤5项标志物的诊断试验与评价[J].检验医学与临床,2017,14(17):2565-2567,2570.
[4]王斐斐,于国华,刘同慎,等.可溶型B7-H3在原发性肝细胞癌患者血清中的表达及临床意义[J].细胞与分子免疫学杂志,2013,29(6):629-632.
[5]江华,刘东斌,梁阔,等.复方氨基酸15双肽2注射液对肝癌术后患者血清肿瘤标志物水平影响研究[J].中国生化药物杂志,2015,35(10):48-50.
[6]Ijichi H,Shirabe K,Taketomi A,et al.Clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography computed tomography for patients with primary liver cancer with special reference to rare histological types,hepatocellular carcinoma with sarcomatous change and combined hepatocellular and cholangiocarcinoma[J].Hepatology research:the official journal of the Japan Society of Hepatology,2013,43(5):481-487.